SYRS Annual Cash & Cash Equivalents
$139.53 M
-$27.94 M-16.68%
31 December 2023
Summary:
As of January 21, 2025, SYRS annual cash & cash equivalents is $139.53 million, with the most recent change of -$27.94 million (-16.68%) on December 31, 2023. During the last 3 years, it has fallen by -$34.46 million (-19.81%). SYRS annual cash & cash equivalents is now -19.81% below its all-time high of $173.98 million, reached on December 31, 2020.SYRS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Quarterly Cash And Cash Equivalents
$58.27 M
-$20.69 M-26.20%
30 September 2024
Summary:
As of January 21, 2025, SYRS quarterly cash and cash equivalents is $58.27 million, with the most recent change of -$20.69 million (-26.20%) on September 30, 2024. Over the past year, it has dropped by -$53.94 million (-48.07%). SYRS quarterly cash and cash equivalents is now -73.77% below its all-time high of $222.14 million, reached on March 31, 2021.SYRS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.7% | -48.1% |
| 3 y3 years | -19.8% | -44.4% |
| 5 y5 years | +179.7% | -44.4% |
SYRS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.7% | +51.2% | -66.0% | at low |
| 5 y | 5-year | -19.8% | +236.7% | -73.8% | +40.6% |
| alltime | all time | -19.8% | +333.2% | -73.8% | +163.3% |
Syros Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $58.27 M(-26.2%) |
| June 2024 | - | $78.96 M(-5.5%) |
| Mar 2024 | - | $83.52 M(-40.1%) |
| Dec 2023 | $139.53 M(-16.7%) | $139.53 M(+24.3%) |
| Sept 2023 | - | $112.22 M(-2.8%) |
| June 2023 | - | $115.44 M(+10.2%) |
| Mar 2023 | - | $104.77 M(-37.4%) |
| Dec 2022 | $167.47 M(+81.4%) | $167.47 M(-2.4%) |
| Sept 2022 | - | $171.53 M(+190.4%) |
| June 2022 | - | $59.06 M(-15.1%) |
| Mar 2022 | - | $69.58 M(-24.6%) |
| Dec 2021 | $92.30 M(-46.9%) | $92.30 M(-20.0%) |
| Sept 2021 | - | $115.42 M(-28.3%) |
| June 2021 | - | $160.91 M(-27.6%) |
| Mar 2021 | - | $222.14 M(+27.7%) |
| Dec 2020 | $173.98 M | $173.98 M(+86.8%) |
| Sept 2020 | - | $93.13 M(-14.3%) |
| June 2020 | - | $108.67 M(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $116.87 M(+182.0%) |
| Dec 2019 | $41.44 M(-16.9%) | $41.44 M(+24.2%) |
| Sept 2019 | - | $33.36 M(-67.2%) |
| June 2019 | - | $101.74 M(+359.8%) |
| Mar 2019 | - | $22.13 M(-55.6%) |
| Dec 2018 | $49.89 M(+54.9%) | $49.89 M(+14.6%) |
| Sept 2018 | - | $43.52 M(-61.9%) |
| June 2018 | - | $114.39 M(+21.3%) |
| Mar 2018 | - | $94.33 M(+192.9%) |
| Dec 2017 | $32.20 M(-45.0%) | $32.20 M(-23.6%) |
| Sept 2017 | - | $42.15 M(-47.0%) |
| June 2017 | - | $79.53 M(+65.7%) |
| Mar 2017 | - | $48.00 M(-18.1%) |
| Dec 2016 | $58.59 M(+63.2%) | $58.59 M(-37.3%) |
| Sept 2016 | - | $93.49 M(+86.6%) |
| June 2016 | - | $50.12 M(-19.3%) |
| Mar 2016 | - | $62.13 M(+73.0%) |
| Dec 2015 | $35.91 M(-40.5%) | $35.91 M |
| Dec 2014 | $60.39 M | - |
FAQ
- What is Syros Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Syros Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Syros Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of SYRS is $139.53 M
What is the all time high annual cash & cash equivalents for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual cash & cash equivalents is $173.98 M
What is Syros Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, SYRS annual cash & cash equivalents has changed by -$27.94 M (-16.68%)
What is Syros Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SYRS is $58.27 M
What is the all time high quarterly cash and cash equivalents for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly cash and cash equivalents is $222.14 M
What is Syros Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, SYRS quarterly cash and cash equivalents has changed by -$53.94 M (-48.07%)